glp-1 class drugs likely to be helpful for additional indications WHO Backs Use Of GLP-1

Emerging strategies in drug development and clinical care in the era of personalized and precision medicine

Key findings across Phase II and III trials: Women receiving PT-141 showed statistically significant increases in satisfying sexual events per month compared to placebo Reduction in sexual distress scores was observed across multiple validated instruments Effects were noted within the first treatment cycle and maintained across the 12-week study period Response was not limited to any one demographic subgroup efficacy was consistent across age ranges within the premenopausal population Research Context for Male Sexual Dysfunction While PT-141s FDA approval is specifically for HSDD in women, substantial preclinical and Phase II research has examined its effects in men particularly in cases where psychological or neurological factors contribute to sexual dysfunction that vascular agents alone cannot address

Higher circulating glutathione means your cells including skin cells are better protected from oxidative damage

N c cho l gip gim bt lo lng, cng thng v gim chng mt ng